Home › NDC Lookup › Ingredients › Chlorpheniramine Maleate › 49483-0242-10
Allergy Time Chlorpheniramine Maleate 4 mg Tablet, 1,000-count — NDC 49483-0242-10 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Allergy Time Chlorpheniramine Maleate 4 mg Tablet, 1,000-count — NDC 49483-242-10 (Billing 49483-0242-10)

by Time Cap Labs Inc · 1000 TABLET in 1 BOTTLE, PLASTIC

This is a package of 1,000 tablets of Allergy Time Chlorpheniramine Maleate 4 mg Tablet from Time Cap Labs Inc, marketed since Feb 2011 and currently FDA-listed; retail pharmacies pay about $0.0177 per tablet (NADAC).

NDC 49483-0242-10
🏷️ FDA NDC (as labeled) 49483-242-10 billing pads the product segment with a zero
This package
Contains1,000-count Cost per ea$0.0177 NADAC Per package$17.70 / 1000 tablets Pack sizes4 compare ↓
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 49483-242-10 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
49483 labeler · 242 product · 10 package
Package marketed since
Dec 17, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
1,000 EA per package
Barcode (UPC)
0349483242010
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 49483-242-10
Product NDC 49483-242
11-digit billing NDC 49483024210
NCPDP billing unit EA — each (per item)
RxCUI 1363309
UNII V1Q0O9OJ9Z
UPC 0349483242010
Application # part341
SPL Set ID 588c424a-8dd6-417e-8f76-2ce0cc2b0c12
Established class (EPC) Histamine-1 Receptor Antagonist
Mechanism of action Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH FINAL
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2011-02-08
Route ORAL
Dosage form TABLET
Substance CHLORPHENIRAMINE MALEATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 41100020150310
GPI class Allergy-Time
GCN Seq No 011640
GCN 46512
HICL code 004505
Ingredient (HICL) Chlorpheniramine Maleate
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2P
Therapeutic class — specific (HIC3) Antihistamines - 1St Generation
AHFS code 04:04.00.00
AHFS class First Generation Antihistamines
FDB label name ALLERGY-TIME 4 MG TABLET
FDB brand name Allergy-Time
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 011640
  • GCN: 46512
  • GPI-14 (Medi-Span): 41100020150310
  • HICL (First Databank): 004505
  • AHFS class code: 04:04.00.00
  • RxCUI (RxNorm): 1363309
Why two NDCs? The FDA registers this code as 49483-242-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 49483-0242-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Substituted alkylamines
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ALLERGY-TIME 4 MG TABLET Ingredient Chlorpheniramine Maleate
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves allergy symptoms from hay fever and other upper respiratory allergies. That means sneezing, runny nose, itchy, watery eyes, and an itchy nose or throat. It...
  • It depends on the product. Regular tablets and the liquid are generally taken every 4 to 6 hours. The extended-release tablets are taken about every 12 hours. Check your package fo...
  • It can, and the drowsiness may be marked. Be careful driving or using machinery. Some people, especially children, can get excitable instead.
  • It's best to avoid alcohol, since it adds to drowsiness. Sedatives and tranquilizers can also increase drowsiness, so talk to me or your doctor before taking them together.
📖 Read our full Chlorpheniramine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.018 $17.70 / 1000 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.020 $0.015
▼ Down 8% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
49483-0242-00 49483-242-00 100000 TABLET in 1 CARTON — — 2018-12-17 — Active
49483-0242-01 49483-242-01 Main listing 100 TABLET in 1 BOTTLE, PLASTIC $0.0177 / ea $1.77 2018-12-17 — Active
49483-0242-10 You're viewing this 1000 TABLET in 1 BOTTLE, PLASTIC $0.0177 / ea $17.72 2018-12-17 — Active
49483-0242-24 49483-242-24 24 TABLET in 1 BLISTER PACK — — 2018-12-17 — Active

You're viewing one of 4 pack sizes for this product.

This pack effectively ties for the lowest per-ea cost of the 2 priced pack sizes ($0.0177 NADAC).

Pack size FAQ

What quantity is in this package?
This is a 1,000-count package — 1000 tablet in 1 bottle, plastic.
How does this package differ from NDC 49483-0242-24?
Both are Allergy Time Chlorpheniramine Maleate 4 mg Tablet — the drug itself is identical. This page's package is the 1,000-count one, while NDC 49483-0242-24 is the 24 tablets package.
What NDC number is used to bill for this package of Allergy Time Chlorpheniramine Maleate 4 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Allergy Relief 4 Hour 4 mg 70000-0160-01 Cardinal 24 tablets $0.018 — Discontinued save 1%
Allergy 4 mg 00904-0012-24 Major 24 tablets $0.018 — Availability likely —
Allergy Relief 4 mg 46122-0618-62 Amerisource 24 tablets $0.018 — Availability likely —
Allergy Time 4 mgthis 49483-0242-10 Time 1000 tablets $0.018 — Availability likely —
Allergy Relief 4 mg 70677-1016-01 Strategic 100 tablets $0.018 — Availability likely —
Allergy Relief 4 mg 83324-0068-24 Chain 24 tablets $0.018 — Availability likely —
Aller-chlor 4 mg 00536-1006-01 Rugby 100 tablets $0.018 — Availability likely —
Allergy Relief 4 mg 00363-1941-15 Walgreen 50 tablets — — FDA listed —
allergy relief 4 mg 11822-0662-01 Rite 100 tablets — — FDA listed —
Anti Allergy 4 mg 17714-0016-01 Advance 100 tablets — — FDA listed —
Allergy Relief 4 mg 36800-0694-08 Topco 24 tablets — — FDA listed —
Allergy 4 mg 37835-0633-01 Bi-Mart 100 tablets — — FDA listed —
Allergy 4 mg 41163-0194-08 United 24 tablets — — FDA listed —
Medique Chlorphen 4 mg 47682-0169-46 Unifirst 1 tablet — — FDA listed —
Allergy 4 mg 50090-0049-00 A-S 100 tablets — — FDA listed —
Allergy Relief 4 mg 50804-0277-93 Good 24 tablets — — FDA listed —
Sprinsol 4 mg 51467-0101-01 FORTUNE 24 tablets — — FDA listed —
Chlorpheniramine maleate 4mg 4 mg 53185-0277-24 Athlete's 24 tablets — — FDA listed —
Anti Allergy 4 mg 54738-0103-01 Richmond 100 tablets — — FDA listed —
Chlorpheniramine Maleate 4 mg 55289-0560-01 PD-Rx 100 tablets — — FDA listed —
Allergy Relief 4 Hour 4 mg 57896-0974-01 Geri-Care 100 tablets — — FDA listed —
Allergy Relief 4 mg 63868-0333-24 CHAIN 24 tablets — — FDA listed —
Allergy Relief 4 Hour 4 mg 67091-0203-24 WinCo 24 tablets — — FDA listed —
Allergy Relief 4 mg 68016-0683-81 Chain 100 tablets — — FDA listed —
Allergy 4 mg 68998-0277-93 Marc 24 tablets — — FDA listed —
Allergy 4 mg 69168-0277-93 Allegiant 24 tablets — — FDA listed —
Allergy Relief 4 mg 69842-0194-12 CVS 100 tablets — — FDA listed —
Chlorpheniramine Maleate 4 mg 71335-0963-01 Bryant 30 tablets — — FDA listed —
Allergy 4 mg 71335-2056-01 Bryant 30 tablets — — FDA listed —
Allergy Relief 4 mg 71335-2812-01 Bryant 100 tablets — — FDA listed —
Allergy Relief 4 Hour 4 mg 71335-3093-01 Bryant 30 tablets — — FDA listed —
Pharbechlor 4 mg 73057-0346-11 Ulai 1000 tablets — — FDA listed —
Allergy Relief 4 mg 79903-0074-12 WALMART 100 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2011
On the market since
Feb 2011
📍
2026
Currently FDA-listed
15 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Chlorpheniramine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3SY5LH9PMK
    Anhydrous lactose is a milk sugar with no water content. It acts as a filler and binder in tablets and capsules, adding bulk and helping ingredients stick together.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII 35SW5USQ3G
    A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesanhydrous lactose, colloidal silicon dioxide, croscarmellose sodium, D-C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose, stearic acid.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerTime Cap Labs Inc
FDA applicationpart341 (OTC MONOGRAPH FINAL)
Labeler code49483
First marketedFeb 2011
Product typeHuman Otc Drug
Portfolio6 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 27 words ▾

Uses: temporarily relieves the following symptoms due to hay fever or other upper respiratory allergies: runny nose, sneezing, itching of the nose or throat, itch, watery eyes

⏱️ Dosage and Administration 63 words ▾

Directions Adults and children 12 years and over - 1 tablet every 4 to 6 hours, not to exceed 6 tablets in 24 hours Children 6 to under 12 years of age - 1/2 tablet (break tablet in half) every 4 to 6 hours, not to exceed 3 whole tablets in 24 hours Children under 6 years of age - do not use

⚠️ Warnings 27 words ▾

Warnings Ask a doctor before use if you have: glaucoma; a breathing problem such as emphysema or chronic bronchitis; difficulty urinating due to an enlarged prostate gland

🧪 Active Ingredient 9 words ▾

Active ingredient (in each tablet) Chlorpheniramine maleate 4 mg

🧪 Inactive Ingredients 18 words ▾

anhydrous lactose, colloidal silicon dioxide, croscarmellose sodium, D-C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose, stearic acid.

🎯 Purpose 2 words ▾

Purpose: Antihistamine

📄 Ask a Doctor or Pharmacist Before Use If 14 words ▾

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

📄 When Using This Product 32 words ▾

When using this product: excitability may occur, especially in children; drowsiness may occur; avoid alcoholic beverages; alcohol, sedatives and tranquilizers may increase drowsiness; use caution when driving a motor vehicle operating machinery

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 3 words ▾

100 CT LABEL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Allergy Time (this brand).

Top reported reactions

Nausea566
Diarrhoea527
Fatigue442
Dyspnoea410
Pyrexia394
Vomiting375
Neutropenia289

Age at onset

Neonate9
Infant7
Child33
Adolescent34
Adult685
Elderly450

Reporter sex

5,666 reports
Male · 42%
Female · 58%
Unknown · 0%

Serious outcomes

Hospitalization2,742
Life-threatening554
Disabling235
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 799 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.